NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Veravas

Veravas

Private
Austin, TexasHealthcare & Life Scienceshttps://veravas.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Veravas is a diagnostics technology company that provides a platform to manage sample preparation and diagnostic solutions for early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's detectionearly disease detectionbiomarker purificationliquid biopsysample preparationblood test for Alzheimer'slow-abundance biomarkersbiomarker enrichmentdiagnostic assaysmagnetic nanobeadslaboratory-developed testLDTneurodegenerative disease diagnosticsresearch-use-onlyRUOdiagnostic reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veravas Comps

Public and private peers based on sector, stage, and business model.

Veravas comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Veravas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
Convertible DebtFeb 19, 2020

Key People

Founding team and executive leadership

Joshua Soldo

Chief Scientific Officer & Co-Founder

Founding Team

Nancy Carson

Chief Operating Officer

Executive Team

Veravas Investors

Notable investors and investment history

Veravas investors
InvestorRounds
MedTech InnovatorAccelerator
American Heart Association VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 287% MoM.

  • Jan 21, 2026

    Monthly visitors increased 53% MoM.

Veravas Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veravas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veravas's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range20
Year Founded2017
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.